ORIC Pharmaceuticals (ORIC) Insider Trading & Ownership $10.33 -0.01 (-0.10%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ORIC Pharmaceuticals (NASDAQ:ORIC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.55%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$519,920.04 Get ORIC Insider Trade Alerts Want to know when executives and insiders are buying or selling ORIC Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORIC Insider Buying and Selling by Quarter ORIC Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/16/2024Dominic PiscitelliCFOSell8,851$8.28$73,286.28 12/16/2024Jacob ChackoCEOSell24,660$8.28$204,184.80 12/16/2024Pratik S MultaniInsiderSell8,850$8.28$73,278.00 2/6/2024Jacob ChackoCEOSell13,958$12.12$169,170.96 (Data available from 1/1/2013 forward) ORIC Insider Trading Activity - Frequently Asked Questions Who is on ORIC Pharmaceuticals's Insider Roster? The list of insiders at ORIC Pharmaceuticals includes Dominic Piscitelli, Jacob Chacko, and Pratik S Multani. Learn more on insiders at ORIC. What percentage of ORIC Pharmaceuticals stock is owned by insiders? 5.55% of ORIC Pharmaceuticals stock is owned by insiders. Learn more on ORIC's insider holdings. Which ORIC Pharmaceuticals insiders have been selling company stock? The following insiders have sold ORIC shares in the last 24 months: Dominic Piscitelli ($73,286.28), Jacob Chacko ($777,600.82), and Pratik S Multani ($118,650.38). How much insider selling is happening at ORIC Pharmaceuticals? Insiders have sold a total of 110,984 ORIC Pharmaceuticals shares in the last 24 months for a total of $969,537.48 sold. ORIC Pharmaceuticals Key ExecutivesDr. Richard A. Heyman Ph.D. (Age 67)Co-Founder, Independent Chairman & Member of Scientific Advisory Board Compensation: $93kDr. Jacob M. Chacko M.B.A. (Age 45)M.D., President, CEO & Director Compensation: $961kMr. Dominic G. Piscitelli CPA (Age 49)M.B.A., Chief Financial Officer Compensation: $654.74k1 recent tradesDr. Pratik S. Multani M.D. (Age 57)M.S., Chief Medical Officer Compensation: $715.22kDr. Charles L. Sawyers B.A. (Age 65)M.D., Ph.D., Co-Founder & Member of Scientific Advisory Board Dr. Scott W. Lowe Ph.D.Co-Founder & Member of Scientific Advisory BoardDr. Lori Sickels Friedman Ph.D. (Age 60)Chief Scientific Officer Dr. Christian V. Kuhlen Esq. (Age 51)J.D., M.D., General Counsel Mr. Daniel IazzettiVP & Head of PeopleDr. Edna Chow Maneval (Age 64)Senior Vice President of Clinical Development More Insider Trading Tools from MarketBeat Related Companies Merus Insider Buying Bausch Health Companies Insider Buying Kymera Therapeutics Insider Buying SpringWorks Therapeutics Insider Buying Amneal Pharmaceuticals Insider Buying Recursion Pharmaceuticals Insider Buying Gemini Therapeutics Insider Buying Edgewise Therapeutics Insider Buying Arrowhead Pharmaceuticals Insider Buying Mirum Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys This page (NASDAQ:ORIC) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ORIC Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
